ArticleArthritis research & therapy2014

Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study.

Avram Goldberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.